Blood and bone marrow cancers linked to higher brain tumor risk
Original title: Increased glioblastoma risk in patients with myeloproliferative neoplasms and myelodysplastic syndromes.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This looked at health records and genes in people, not a new treatment.
The short version
People with two kinds of blood and bone marrow cancer may face a higher risk of a brain tumor.
What was studied. Researchers pooled two large world health databases and gene data. They studied two blood and bone marrow diseases, called MPN and MDS, and tumors of the brain and spine. They also tracked case records in Sweden from 1990 to 2021.
What they found. The two blood diseases and brain tumors were both heaviest in developed regions. In Sweden, the blood diseases came before brain tumors, and that pattern showed up only in women. The gene part of the study found that MPN and MDS each raise the chance of getting glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary. The authors suggest the link may involve the immune system and swelling in the body.
What this means, and what it doesn't
What it could mean: If you have MPN or MDS, new brain symptoms are worth reporting to your care team. Things like new headaches, vision changes, or seizures should be checked. It may also help to have your blood doctor and a brain doctor talk to each other.
What it doesn't mean: This does not prove that one disease causes the other. The study looked back at records and gene patterns, not at patients in a trial. There is no new test or treatment here that you can ask for. Most people with these blood diseases will never get a brain tumor. This is early research, far from everyday care, and it is not a promise of a cure.
Source: PubMed, August 22, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.